SYNLAB AG
SYAB.DE
$-0.02
Change (1 day)
$13.11
Year High
$8.46
Year Low
Categories
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
P/E ratio for SYNLAB AG (SYAB.DE)
P/E ratio as of 2023: 27.19
According to SYNLAB AG's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 27.19. At the end of 2022 the company had a P/E ratio of 16.66.
P/E ratio history for SYNLAB AG from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 27.19 |
| 2022 | 16.66 |
| 2021 | 8.13 |
| 2020 | 112.69 |
| 2019 | -213.10 |
| 2018 | -506.58 |
| 2017 | -156.79 |
| 2016 | -98.77 |
| 2015 | -134.75 |